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Purpose: To identify significant fluorescein angiographic (FA) characteristics asso-
ciated with visual acuity (VA) in Behçet retinal vasculitis. Materials and Methods: 
Retrospective review of 86 eyes of 48 patients (age: 35.6±10.2 years) with Behçet 
retinal vasculitis were performed. VA and FA findings as well as correlation be-
tween them were assessed. Results: The mean initial VA of eyes with posterior 
pole-involved vasculitis (63 eyes; 73.3%) was significantly worse than that of those 
with peripheral vasculitis (23 eye; 26.7%) (logarithm of the minimum angle of res-
olution VA: 0.554±0.572 vs. 0.078±0.148; p<0.0001). Subgroup analysis revealed a 
more severe and diffuse pattern of vascular leakage in posterior pole-involved vas-
culitis compared to peripheral vasculitis (p<0.0001). Retinal vascular leakage 
(β=0.345; p<0.0001), optic disc hyperfluorescence (β=0.147; p=0.032), and macu-
lar leakage (β=0.107; p=0.047) were significantly associated with worse initial VA. 
During the follow up (mean: 33.3±17.9 months), the change of leakage showed no 
significant correlation with change of VA in posterior pole-involved vasculitis 
(τ=0.199, p=0.092). Conclusion: Posterior pole involvement, the degree of retinal 
vascular leakage, optic disc hyperfluorescence, and macular leakage are significant-
ly associated with VA in Behçet retinal vasculitis.
Key Words:   Behçet retinal vasculitis, ocular Behçet disease, fluorescein angiog-
raphy, visual acuity
INTRODUCTION
Behçet disease is a chronic and recurrent multisystem inflammatory disorder of un-
known etiology. Although its exact pathogenesis remains unclear, the underlying 
pathology is an obliterative vasculitis that affects both the arteries and veins in all 
organs.1 Ocular involvement, which can include anterior uveitis, vitritis, retinal vas-
culitis, optic neuropathy, and scleritis, occurs in approximately 70% of Behçet’s 
cases, and the visual prognosis for a patient with posterior segment inflammation is 
generally considered to be poor.2 Among many ocular manifestations, retinal vascu-
litis has been reported to be one of the most common ocular findings and suggested 
to be significantly correlated with visual prognosis in many studies.3-5 As chronic 
and recurrent inflammation of retinal vessels is of major concern in Behçet retinal 
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lar inflammation, presence of any other disease, such as dia-
betic retinopathy and age-related macular degeneration, that 
could contribute to vascular leakage, inability to visualize 
the fundus due to a severe media opacity such as a dense 
cataract or a vitreous opacity, posterior synechiae, cataract or 
retinal surgery during the follow-up period, and macular pa-
thologies, such as epiretinal membrane, macular holes, and 
optic nerve atrophy. In total, 86 eyes of 48 patients (27 males 
and 21 females; 10 patients with unilateral involvement; 
mean age: 35.63±10.18 years) were finally enrolled in the 
study. 
Data collection
The demographic and clinical data gathered were age at the 
time of diagnosis, gender, laterality, HLA-B51 status, duration 
of follow up, best corrected Snellen visual acuity (BCVA) at 
initial presentation, at 2 years within +/- six months and at 
the last follow up. For BCVA at 2 years, the visit closest to 
the 2 year time point within a 3 months window was count-
ed as the visit to be used. All patients were examined by the 
same uveitis specialist (SCL). Ophthalmic examinations in-
cluded a slit lamp examination, a dilated fundus examina-
tion, and measurement of the intraocular pressure. Further, 
the Standardization of Uveitis Nomenclature (SUN) Group 
grading scheme was used for the assessment of the degree 
of inflammation in the anterior chamber and the vitreous.13 
Patients underwent FA and optical coherence tomography 
(OCT) for the evaluation of retinal vasculitis and macular 
edema. FA findings at initial presentation and at 2 years 
within +/- three months were graded according to the FA 
classification described below. 
For a change in VA to be considered as an improvement, 
there had to be an improvement of at least three Snellen 
chart lines between the initial VA and VA at 2 year time 
point within a 3 months window, whereas a drop of at least 
three Snellen chart lines was considered a worsening of VA. 
A change in VA of fewer than three lines was regarded as no 
change. 
Imaging
Fluorescein angiography 
Images were obtained with a confocal scanning laser oph-
thalmoscope (HRA 2; Heidelberg Engineering, Heidelberg, 
Germany). The images were selected from multiple early-
phase and late-phase FA images, and analyzed by experi-
enced, independent retinal specialists (MK and SCL). 
vasculitis due to the cumulative damage it causes to retinal 
structures,6 the identification of specific angiographic find-
ings of such pathology and their association with visual acu-
ity (VA) bear clinical significance. 
Fluorescein angiography (FA) is essential in assessing the 
activity and extent of the inflammation and monitoring the 
response to treatment in Behçet retinal vasculitis. FA allows 
for the recognition of retinal vascular inflammation based on 
fluorescein dye leakage from compromised retinal vessels 
as the breakdown of the inner blood retinal barrier occurs.7
Previous studies have explored the clinical features of 
Behçet uveitis in general.5,8 Although a few reports have de-
scribed the fluorescein and indocyanine green angiographic 
findings in ocular Behçet’s disease,9-11 the correlations be-
tween various FA findings and VA were not taken into con-
sideration in these studies. Further, the impact of vascular 
leakage severity and its changes on VA have not been previ-
ously explored.
In this retrospective study, we intend to identify clinically 
significant FA findings that are associated with VA and as-
sess the correlations between changes of FA findings and 
VA in Behçet retinal vasculitis. 
MATERIALS AND METHODS
Patient selection
A retrospective review was performed of the medical re-
cords of 68 consecutive patients with active retinal vasculitis 
associated with Behçet disease who had been examined be-
tween January 2007 and March 2011 at the Behçet Uveitis 
Clinic at the Yonsei University Medical Center. The study 
was approved by the Institutional Review Boards at the 
Yonsei University Medical Center (IRB approval number: 
4-2011-0829) and was performed in accordance with the te-
nets of the Declaration of Helsinki and all federal laws. In-
clusion of patients were based on the following criteria. 
First, patients that satisfied the diagnostic criteria of the In-
ternational Study Group for Behçet disease12 were identi-
fied. Then, their FA were retrospectively evaluated for signs 
of retinal vasculitis such as vascular sheathing or leakage 
and staining of the retinal capillaries or large vessels in FA. 
Only patients who presented with their first episode of ac-
tive retinal vascular inflammation were included in the study. 
The exclusion criteria were as follows: concurrent active 
infection, a history of tuberculosis, sarcoidosis, end-stage 
vasculitis with no light perception, a previous history of ocu-
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anatomical location of the retinal vascular leakage. Those 
that exhibited leakage within the posterior pole were classi-
fied as having posterior pole-involved vasculitis, and those 
that only showed angiographic leakage in the periphery 
were defined as having peripheral vasculitis. The extent of 
the vascular leakage was classified as either focal-type in 
cases where there was a specific focus of dye leakage and/or 
if a well-defined focal area of leakage could be localized to 
within one quadrant, or diffuse-type if there was widespread 
leakage and/or a large area of multifocal leakage that in-
volved more than one quadrant and did not have a specific 
focus of dye leakage (Fig. 2). 
After classification based on the anatomical location of 
the leakage, those with posterior pole leakage were further 
evaluated to determine whether the macula was involved. 
Macular leakage was graded based on FA findings accord-
ing to criteria previously proposed by Yannuzzi16 in which 
grade 0 equals no perifoveal hyperfluorescence, grade 1 in-
dicates incomplete perifoveal hyperfluorescence, grade 2 
indicates mild 360° hyperfluorescence, grade 3 indicates 
moderate 360° hyperfluorescence with the hyperfluorescent 
area being approximately 1 disc diameter across, and grade 
4 indicates severe 360° hyperfluorescence with the hyper-
fluorescent area being approximately 1.5 disc diameters 
across (Fig. 3).
For the grading of the severity of the retinal vascular leak-
age in the late angiographic phases, a grading system similar 
to that used previously by others was adopted.14,15 Leakage 
was classified as mild for staining of vessels with minimal 
leakage, moderate for more intense leakage with a distinct 
vascular margin, and severe for even greater leakage with 
We devised a grading system for retinal vasculitis by 
slightly modifying a grading criteria previously used in sev-
eral studies.14-16 All classifications were based on the late 
phase of angiograms. The macular and posterior pole re-
gions were delineated through the use of an image overlay 
with measuring capability that was built into the HRA sys-
tem. To define a macular region of interest, an overlayed cir-
cle with a diameter of 1.5 mm was centered on the fovea in 
an FA image. To define the posterior pole, an overlayed cir-
cle with a diameter of 5.5 to 6.0 mm that approximated both 
the superior and inferior temporal vascular arcades was used 
(Fig. 1).
Eyes with retinal vasculitis were classified based on the 
Fig. 1. An overlayed circle of diameter 5.5 mm was centered on the fovea to 
define the posterior pole region approximating the superior and inferior 
temporal vascular arcades in a patient with Behçet retinal vasculitis (the 
outer circle). The macular region was delineated with another overlayed 
circle of diameter 1.5 mm centered on the fovea (the inner circle).
Fig. 2. Fluorescein angiogram showing focal leakage (A, arrow pointing at a focal leakage site at the infero-temporal quadrant) and diffuse vascular staining 
and leakage (B) in Behçet retinal vasculitis.
A B
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optic disc hyperfluorescence, and macular leakage were 
compared collectively between the initial FA and FA at 2 
year time point (within +/- three months) in which the visit 
closest to the 2 year time point within a three month win-
dow was counted as the visit to be used. Then, they were 
categorized into three patterns. A change in the magnitude of 
the overall vascular leakage was considered an improve-
ment or worsening of the leakage, depending on the direc-
tion of the change, whereas, the eye was considered to have 
had no change in vascular leakage, if there was no discern-
ible difference in the degree of leakage. FA analysis was 
performed by two independent observers (MK and SCL) 
who were blind to the other’s reading and the relevant clini-
cal characteristics of the patients (such as VA and slit lamp 
blurring of the large vessel margins (Fig. 4). In vasculitis in-
volving the posterior pole, grading was performed with re-
gard to only the retinal vessels outside the macular area to 
avoid the inclusion of the small vessel leakage associated 
with macular leakage in this grade.
Optic disc hyperfluorescence in the late angiographic 
phases was also graded using a system similar to that used 
previously by others.14,15 Hyperfluorescence was categorized 
as none (normal exiting of fluorescein and normal staining 
of the scleral rim), partial (partial staining of the optic disc), 
diffuse (diffuse leakage without blurring of the disc margin), 
and diffuse with blurring of the disc margin (Fig. 5). 
For the evaluation of the change in vascular leakage dur-
ing follow up, the magnitudes of retinal vascular leakage, 
Fig. 3. Fluorescein angiograms demonstrating different grades of macular leakage in Behçet retinal vasculitis. Grade 1, incomplete perifoveal hyperfluores-
cence (A); grade 2, mild 360° hyperfluorescence (B); grade 3, moderate 360° hyperfluorescence with the hyperfluorescent area being approximately 1 disc 
diameter across (C); grade 4, severe 360° hyperfluorescence with the hyperfluorescent area being approximately 1.5 disc diameters across (D).
A
C
B
D
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an individual. Kendall’s tau beta coefficient was calculated 
for the correlation analysis of the relationship between the 
changes of VA and leakage during follow up at 2 year time 
point within a 3 months window. 
p-values less than 0.05 were considered statistically sig-
nificant SAS software version 9.2 (SAS Institute Inc., Cary, 
NC, USA) was used for the statistical analyses.
RESULTS
Retinal vasculitis was classified into two types based on the 
anatomic location involved. As shown in Table 1, retinal vas-
culitis involved the posterior pole in 63 eyes (73.3%), all of 
which also showed vascular leakage in the periphery. Isolat-
ed peripheral involvement (i.e., no vascular leakage in the 
posterior pole) was found in 23 eyes (26.7%). The mean 
logarithm of the minimum angle of resolution (logMAR) 
VA for eyes with vasculitis involving the posterior pole was 
significantly worse than that of those with peripheral vasculi-
tis (p<0.0001). These two groups did not differ in the pres-
findings). Any disagreement on the FA findings was re-
solved by open adjudication. 
Statistical analysis
The VA, demographics, and angiographic findings at initial 
presentation were analyzed with the Pearson chi-square test 
(Fisher’s exact test was used when the expected cell counts 
were less than five) or independent Student’s t-test (or Mann-
Whitney U test). Mantel-Haenszel chi-square analysis was 
done to assess any trends in the level of retinal vascular 
leakage and optic disc hyperfluorescence in peripheral and 
posterior pole-involved vasculitis. The Cohen’s kappa coef-
ficient was calculated to evaluate intergrader and intragrader 
reliability by measuring chance-adjusted agreement for an-
giographic grading.
In vasculitis involving the posterior pole, multivariable 
linear regression analysis was performed with initial VA as 
the dependent variable and the angiographic features as in-
dependent variables after adjusting for potential confound-
ers. A compound symmetry covariance structure was used 
to account for potential correlations between the two eyes of 
Fig. 4. Fluorescein angiograms demonstrating different degrees of retinal vascular leakage in Behçet retinal vasculitis. Mild, staining of vessels with minimal 
leakage (A); moderate, more intense leakage with a distinct vascular margin (B); severe, even greater leakage with blurring of the large vessel margins (C).
A B C
Fig. 5. Fluorescein angiograms of Behçet retinal vasculitis demonstrating varying degrees of optic disc hyperfluorescence. Partial (A); diffuse with clear disc 
margin (B); diffuse with blurring of the disc margin (C).
A B C
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diffuse with blurring of disc margin: 9.3%). Subgroup anal-
ysis (based on anatomic location) revealed a significant trend 
towards a more severe and diffuse-type of vascular leakage 
in retinal vasculitis involving the posterior pole compared to 
peripheral vasculitis (Mantel-Haenszel chi-square test, all 
p<0.0001). In contrast, most of the eyes with peripheral vas-
culitis had only a mild degree of retinal vascular leakage 
ence of cataracts, the magnitude of anterior uveitis, and pos-
terior vitreous inflammation (all p>0.05, data not shown). 
Regarding the extent of vascular leakage, a diffuse-type of 
retinal vascular leakage was found in 69 eyes (80.2%), 
whereas 17 eyes were classified as focal-type (19.8%). Reti-
nal vascular leakage was accompanied by optic disc in-
volvement in 71 eyes (82.6%, partial: 39.5%, diffuse: 33.7%, 
Table 1. Fluorescein Angiography Findings in Behçet  Retinal Vasculitis
Total
Peripheral 
vasculitis*
Vasculitis involving posterior pole†
p value¶ 
Total Macular‡ Extramacular§ p valueǁ
Number of eyes (%) 86 23 (26.7) 63 (73.3) 51 (59.3) 12 (19.0) NA NA
Age (yrs) 35.63±10.18   32.0±10.20 36.78±9.98 35.42±12.49 37.10±9.41 0.60†† 0.067††
HLA B-51 (%) 35 (40.7) 11 (47.8) 24 (38.1) 22 (34.9)   2 (3.17) 0.11** 0.20**
Initial VA (logMAR) 0.427±0.537 0.078±0.148   0.554±0.572 0.560±0.566   0.529±0.619 0.87†† <0.0001††
Follow-up VA§§ (logMAR) 0.439±0.529 0.087±0.181   0.568±0.557 0.618±0.576   0.354±0.426 0.14†† <0.0001††
Follow-up duration (months) 33.3±17.9 30.1±18.9   34.4±17.7 35.4±18.9   25.1±17.7 0.091†† 0.33††
Extent of leakage (%) <0.0001**
Focal 17 (19.8) 17 (73.9) 0 (0.0) 0 (0.0) 0 (0.0) 0.99**
Diffuse 69 (80.2)   6 (26.1) 63 (91.3) 51 (80.9) 12 (19.1)
Degree of retinal vascular  
  leakage (%)
0.012‡‡ <0.0001‡‡
Mild 46 (53.5) 22 (95.6) 23 (36.5) 14 (27.5)   9 (75.0)
Moderate 28 (32.6) 1 (4.4) 28 (44.4) 26 (51.0)   2 (16.7)
Severe 12 (14.0) 0 (0.0) 12 (19.0) 11 (21.6) 1 (8.3)
Optic disc hyperfluorescence (%)
None 15 (17.4)   7 (30.4)   8 (12.7)   6 (11.8)   2 (16.7) 0.50‡‡ 0.11‡‡
Partial 34 (39.5)   8 (34.8) 26 (41.3) 23 (45.1)   3 (25.0)
Diffuse with clear disc  
  margin
29 (33.7)   8 (34.8) 21 (33.3) 15 (29.4)   6 (50.0)
Diffuse with blurring of  
  disc margin
8 (9.3) 0 (0.0)   8 (12.7)   7 (13.7) 1 (8.3)
Ischemic change (%)
Peripheral Capillary  
  nonperfusion
15 (17.4)   3 (13.0) 12 (19.0)   8 (15.7)   4 (33.3) 0.22‡‡ 0.75‡‡
Vascular anastomosis 22 (25.6) 0 (0.0) 22 (34.9) 17 (33.3)   5 (41.7) 0.74** 0.002**
NVE 2 (2.3) 0 (0.0) 2 (3.2) 0 (0.0)   2 (16.7) 0.034** 0.99**
NVD 1 (1.2) 0 (0.0) 1 (1.6) 1 (2.0) 0 (0.0) 0.99** 0.99**
BRVO 1 (1.2) 0 (0.0) 1 (1.6) 1 (2.0) 0 (0.0) 0.99** 0.99**
Macular ischemia 7 (8.1) 0 (0.0)   7 (11.1)   6 (11.7) 1 (8.3) 0.99** 0.18**
logMAR, logarithm of the minimum angle of resolution; VA, visual acuity; NVE, neovascularization elsewhere; NVD, neovascularization at disc; BRVO, 
branch retinal vein occlusion.
*Peripheral vasculitis refers to eyes with vascular leakage confined to the periphery (i.e., no involvement of the posterior pole).
†Vasculitis involving the posterior pole refers to eyes with vascular leakage that involves the posterior pole. All of these eyes also had vascular leakage in 
the periphery.
‡Macular subtype had involvement of the posterior pole region that included the central 1.5 mm area of the macula.
§Extramacular subtype showed involvement of the posterior pole but no evidence of macular leakage.
ǁComparison between the macular and extramacular subtypes.
¶Comparison between peripheral vasculitis and posterior pole-involved vasculitis.
**Pearson chi-square test (Fisher’s exact test).
††Independent Student’s t-test or Mann-Whitney U test.
‡‡Mantel-Haenszel chi-square test for trend analysis.
§§Follow-up VA at 2 year time point within a 3 month window; p-value<0.05 is considered statistically significant (indicated in italic).
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leakage, k=0.95; change in leakage, k=0.97).
As shown in Table 4, in posterior pole-involved vasculitis, 
no significant correlation was found between the changes in 
vascular leakage and the change in VA evaluated at 2 year 
time point (correlation coefficient τ=0.199, p=0.092). Fur-
thermore, we could not establish any significant correlation 
between the overall change in vascular leakage and the 
change in VA in eyes with peripheral vasculitis at 2 year time 
point (p=0.75).
With regard to treatments, a significantly higher percent-
age of the eyes with posterior pole vasculitis received sys-
temic immunosuppressants (azathioprine, cyclosporin A, 
(95.6%), with one eye displaying moderate retinal vascular 
leakage (4.4%). However, there was not a significant differ-
ence in optic disc hyperfluorescence between the two groups 
(p=0.108). 
Eyes with posterior pole vasculitis were further subdivid-
ed into those that involved the macular region and those 
without any evidence of macular leakage (extramacular sub-
type). Comparison of these two subtypes showed a signifi-
cant trend towards more severe retinal vascular leakage in 
those with macular involvement (p=0.012), but a significant 
difference was not found in optic disc hyperfluorescence 
(p=0.50). There was not a significant difference between 
macular and extramacular types in either initial or follow-up 
VA at the two year time point, but the initial and follow-up 
VA of eyes with peripheral vasculitis were significantly bet-
ter than those of eyes with the extramacular subtype of pos-
terior pole vasculitis (p=0.001 and p=0.005, respectively) 
(Table 1). 
Univariable linear regression analysis identified retinal 
vascular leakage, optic disc hyperfluorescence, and macular 
leakage as factors significantly associated with worse VA in 
the eyes with retinal vasculitis involving the posterior pole 
(all p<0.05) (Table 2). Multivariable regression analysis 
with stepwise variable selection showed that these variables 
remained significantly associated with worse logMAR VA 
after adjusting for potential confounding variables (adjusted 
R2=0.41) (Table 3). However, in peripheral vasculitis, no 
significant association between angiographic findings and 
logMAR VA could be identified (all p>0.05, data not shown).
During the follow-up period (33.3±17.9 months), the 12 
eyes that had vasculitis involving the posterior pole without 
any evidence of angiographic macular leakage (the ex-
tramacular subtype) all remained free of any macular in-
volvement at the final follow up, and did not show a signifi-
cant change in VA (Wilcoxon signed rank test, p>0.05). 
Only one eye (4.3%) with peripheral vasculitis eventually 
progressed to having vasculitis involving the posterior pole. 
This eye developed grade 2 macular leakage over 5 years, 
and the VA decreased from 20/30 to 20/50. 
Inter-grader reliability for grading of angiographic find-
ings of Behçet retinal vasculitis was very favorable (k: kap-
pa value; extent of leakage, k=0.95; degree of retinal vascu-
lar leakage, k=0.96; optic disc hyperfluorescence, k=0.95; 
Macular leakage, k=0.91; change in leakage, k=0.93). Intra-
grader reliability regarding these findings also was favorable 
(extent of leakage, k=1.00; degree of retinal vascular leak-
age, k=0.98; optic disc hyperfluorescence, k=0.98; macular 
Table 2. Factors Associated with Visual Acuity in Posterior 
Pole-Involved Retinal Vasculitis by Univariable Analysis in 
Behçet Retinal Vasculitis
Variables β coefficient
95% 
confidence 
intervals
p value§
Age at initial presentation 0.013 -0.001 to 0.027 0.061
Retinal vascular leakage* 0.397 0.228 to 0.566 <0.0001
Optic disc  
  hyperfluorescence*
0.215 0.057 to 0.373 0.008
Macular leakage* 0.132 0.012 to 0.243 0.013
Anterior chamber cell† 0.088 -0.061 to 0.292 0.20
Vitreous cell‡ 0.068 -0.119 to 0.256 0.47
A univariable linear regression analysis was performed. 
*The magnitude of angiographic parameters was taken into account in 
the analysis.
†Anterior chamber cell: 0, 1+, 2+, 3+, or more.
‡Vitreous cell: 0, 1+, 2+, 3+, or more.
§Statistically significant p-value (<0.05) is indicated in italic.
Table 3. Factors Associated with Visual Acuity in Posterior 
Pole-Involved Retinal Vasculitis by Multivariable Analysis in 
Behçet Retinal Vasculitis
Variables β coefficient
95% 
confidence 
intervals
p value§
Age at initial presentation 0.012 0.001 to 0.024 0.041
Retinal vascular leakage* 0.345 0.162 to 0.528 <0.0001
Optic disc  
  hyperfluorescence*
0.147 0.013 to 0.280 0.032
Macular leakage* 0.107 0.004 to 0.217 0.047
Anterior chamber cell† 0.067 -0.034 to 0.168 0.19
Vitreous cell‡ -0.007 -0.128 to 0.114 0.80
Adjusted R2=0.408. A multivariable regression analysis with stepwise 
variable selection was used.
*The magnitude of angiographic parameters was taken into account in 
the analysis.
†Anterior chamber cell: 0, 1+, 2+, 3+, or more.
‡Vitreous cell: 0, 1+, 2+, 3+, or more.
§Statistically significant p-value (<0.05) is indicated in italic.
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posterior pole involvement, the degree of retinal vascular 
leakage, optic disc hyperfluorescence, and macular leakage 
were significantly associated with worse VA. This suggests 
that the proposed angiographic classification of Behçet reti-
nal vasculitis may be clinically valuable in terms of patients’ 
visual prognosis.
Takeuchi, et al.5 suggested that a lesion located within the 
retinal vascular arcade in ocular Behçet disease is more like-
ly to be associated with an irreversible visual disturbance 
methotrexate) and intravitreal bevacizumab injections com-
pared to those with peripheral vasculitis, but there was no 
significant difference in systemic corticosteroids adminis-
tered between the two groups (Table 5).
DISCUSSION
Our study demonstrated that in Behçet retinal vasculitis, 
Table 5. Systemic Treatment Summary in Patients with Behçet Retinal Vasculitis
Treatment Total
Peripheral 
vasculitis (n=23)
Posterior pole-involved 
vasculitis (n=63)
p value*
Topical steroids (%) 60 (69.8) 18 (78.3) 42 (66.7) 0.43 
Systemic corticosteroids (%) 77 (87.5) 19 (82.6) 56 (88.9) 0.48 
Immunosuppressive agents (%)
Azathioprine 54 (61.4)   8 (34.8) 44 (84.6)   0.006
Cyclosporin A 41 (46.6)   3 (13.0) 37 (58.7)   <0.0001
Colchicine 37 (42.0) 14 (60.9) 22 (34.9)   0.047
Methotrexate 24 (27.3) 1 (4.3) 22 (34.9)   0.005
Posterior subtenon triamcinolone  
  injections (%)
26 (29.5)   3 (13.0) 20 (31.7) 0.10
Intravitreal injections (%)
Triamcinolone 14 (15.9) 2 (8.7) 11 (17.5) 0.50
Bevacizumab 12 (13.6) 0 11 (17.5)   0.032
Methotrexate 6 (6.8) 1 (4.3) 5 (7.9) 0.99 
Immunomodulating agents (%)
Infliximab 2 (2.3) 0 2 (3.2) 0.99
Interferon 8 (9.1) 0   7 (11.1) 0.18 
Cyclophosphamide (%) 5 (5.7) 0 5 (7.9) 0.32
Intravenous steroid pulses (%) 2 (2.3) 0 2 (3.2) 0.99
*Chi-square test (or Fisher’s exact test).
Table 4. Changes in Vascular Leakage and Visual Acuity during Follow Up in Behçet  Retinal Vasculitis
Change in leakage*
Change in VA†
Peripheral retinal vasculitis Posterior pole-involved retinal vasculitis
Overall
Total VA loss
No change 
in VA
VA gain Total VA loss
No change 
in VA
VA gain
Worsened (%)  2 (8.7) 1 (4.3) 1 (4.3)     0 (0) 10 (15.9) 3 (4.8)   7 (11.1) 0 (0) 12 (13.9)
No change (%)  17 (73.9) 1 (4.3) 12 (52.2) 4 (17.4) 32 (50.8) 5 (7.9) 23 (36.5) 4 (6.3) 49 (56.9)
Improved (%)    4 (17.4) 1 (4.3)   3 (13.0)     0 (0) 21 (33.3) 3 (4.8) 13 (20.6) 5 (7.9) 25 (29.1)
Total (%) 23 (100) 3 (13.0) 16 (69.6) 4 (17.4) 63 (100) 11 (17.5) 43 (68.3) 9 (14.3) 86 (100)
Coefficient of correlation
  (Kendall’s tau, τ)
τ=-0.034 (p=0.75) τ=0.199 (p=0.092)
VA, visual acuity. 
Follow up=time interval between the baseline and the closest-to-two year follow-up visit. p-value<0.05 is considered statistically significant.
*Retinal vascular leakage, optic disc hyperfluorescence, and macular leakage were compared collectively between the initial and at 2 year time point 
within a 3 months window. Worsened=there was an increase in the magnitude of the overall vascular leakage, No change=there was no discernible dif-
ference in the degree of leakage, Improved=there was a decrease in the magnitude of the overall vascular leakage. 
†For a change in VA to be considered a gain, there had to be an improvement of at least three Snellen chart lines between the initial VA and VA at 2 year 
time point within a 3 months window. A drop of at least three Snellen chart lines was considered a loss of VA. A change in VA of fewer than three lines 
was regarded as no change.
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evaluate the activity of inflammation might be necessary. 
In this study, there were no cases that progressed from ex-
tramacular vasculitis to vasculitis that involved the macula, 
whereas there was one eye in which the vasculitis progressed 
from involving only the periphery to involving the posterior 
pole 5 years after the time of the initial FA. Considering the 
relatively short mean follow up of 33.3±17.9 months, it is 
unclear whether we might have observed more cases in 
which retinal vasculitis limited to the periphery could prog-
ress to involve the posterior pole, and whether the treatment 
or natural history is what prevented initially peripheral only 
cases from becoming posterior pole involved vasculitis since 
most of peripheral retinal vasculitis have also received vari-
ous treatments. 
There were 12 eyes with retinal vasculitis involving the 
posterior pole that did not have any angiographic evidence 
of macular leakage. Despite the absence of leakage in the 
macular area, the VA of these eyes was not significantly dif-
ferent from that of those with macular leakage, implying 
that vascular inflammation within the posterior pole area 
could have a significant impact on VA even in conditions in 
which there was no apparent involvement of the macular 
area in FA. Several possible mechanisms have been suggest-
ed for the VA decrease that occurs in retinal vasculitis, in-
cluding antiretinal antibodies released from a damaged 
blood retinal barrier causing the apoptotic death of photore-
ceptors,22,23 macular ischemia secondary to occlusive vascu-
litis, persistent leakage of inflammatory mediators such as 
nitric oxide24 and free radicals25 from damaged blood ves-
sels leading to the oxidative stress and apoptotic death of 
photoreceptors,26,27 interference of signal transduction with-
in the inner nuclear layer, and macular thickening due to in-
flammation.
There are several limitations in the present study. We ad-
opted and slightly modified previously used criteria.14-16 
However, there is an inherent subjectivity in grading angio-
graphic leakage. With regard to the evaluation of visual func-
tion, due to the retrospective nature of the study, we were 
able to evaluate only VA. Also, the use of the best or final VA 
outcomes does not accurately reflect the true extent and se-
verity of this disease as the disease tends to wax and wane 
with frequent recurrences,28 and that is why the visit closest 
to the 2 year time point within a 3 months window was 
counted as the visit to be used for correlation between the 
change in vascular leakage and the change in VA. Further 
prospective studies involving more patients with diverse 
ethnic backgrounds are warranted in the future. 
caused by inflammatory cell-mediated damage to photore-
ceptors and ganglion cells in the macula. Optic disc hyper-
fluorescence has been previously suggested to be a marker 
of disease activity in posterior uveitis,17 and Gedik, et al.18 
demonstrated optic disc staining and leakage in 89.8% of 
eyes, a finding similar to our finding of 82.6% of eyes. Pre-
viously, Nussenblatt, et al.19 reported no significant relation-
ship between VA and the amount of fluorescein staining 
measured in the posterior pole. However, in our study, mul-
tivariable regression analysis indicated that the magnitude of 
macular leakage, retinal vascular leakage, and optic disc hy-
perfluorescence were significantly associated with VA. A 
higher prevalence of vascular anastomosis at the time of the 
initial FA suggests that an eye with posterior pole-involved 
retinal vascultis was more likely to have sustained cumula-
tive ischemic damage due to vasoocclusive inflammation 
before the patient was first diagnosed with retinal vasculitis. 
These findings collectively suggest that at initial presenta-
tion, patients with angiographic evidence of retinal vasculitis 
with posterior pole involvement and greater degree of leak-
age may require prompt and aggressive treatment, because 
prolonged retinal vascular inflammation could result in a 
significant alteration of retinal function by promoting retinal 
edema, scarring, and optic nerve dysfunction.20
During follow up, vascular leakage persisted or worsened 
despite treatment with immunosuppressive agents in 61 eyes 
(70.9%), whereas 25 eyes (29.1%) showed an improvement 
in overall vascular leakage. In a subgroup analysis, no sig-
nificant correlation was observed between vascular leakage 
change and VA change (τ=0.199, p=0.092) in eyes with pos-
terior pole-involved retinal vasculitis. Retinal vascular in-
flammation causes the zonulae occludentes to open up and 
the retinal vessels to become leaky, resulting in fluorescein 
leakage through the open intercellular spaces of the endothe-
lium and the staining of the vascular wall and the area sur-
rounding the inflamed vessel.21 This implies that differentia-
tion between progression to active vascular leakage and 
persistent vascular leakage resulting from chronic damage 
incurred on the endothelial blood retinal barrier might be 
difficult in chronic vasculitis such as Behçet retinal vasculi-
tis. Further, mild leakage could persist after the cessation of 
active inflammation as a damaged blood vessel could re-
main leaky for a long time after the active inflammation had 
resolved.20 This may explain the lack of significant correla-
tion between leakage change and VA change in our study. 
To differentiate chronic, inactive inflammation from acute 
exacerbation of active inflammation, additional means to 
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11. Yu HG, Kim MJ, Oh FS. Fluorescein angiography and visual acu-
ity in active uveitis with Behçet disease. Ocul Immunol Inflamm 
2009;17:41-6.
12. Criteria for diagnosis of Behçet’s disease. International Study 
Group for Behçet’s Disease. Lancet 1990;335:1078-80.
13. Jabs DA, Nussenblatt RB, Rosenbaum JT; Standardization of Uve-
itis Nomenclature (SUN) Working Group. Standardization of uve-
itis nomenclature for reporting clinical data. Results of the First In-
ternational Workshop. Am J Ophthalmol 2005;140:509-16.
14. Suhler EB, Smith JR, Wertheim MS, Lauer AK, Kurz DE, Pickard 
TD, et al. A prospective trial of infliximab therapy for refractory 
uveitis: preliminary safety and efficacy outcomes. Arch Ophthal-
mol 2005;123:903-12.
15. Tugal-Tutkun I, Herbort CP, Khairallah M; Angiography Scoring 
for Uveitis Working Group (ASUWOG). Scoring of dual fluores-
cein and ICG inflammatory angiographic signs for the grading of 
posterior segment inflammation (dual fluorescein and ICG angio-
graphic scoring system for uveitis). Int Ophthalmol 2010;30:539-52. 
16. Yannuzzi LA. A perspective on the treatment of aphakic cystoid 
macular edema. Surv Ophthalmol 1984;28 Suppl:540-53.
17. Ciardella AP, Prall FR, Borodoker N, Cunningham ET Jr. Imaging 
techniques for posterior uveitis. Curr Opin Ophthalmol 2004;15: 
519-30.
18. Gedik S, Akova Y, Yilmaz G, Bozbeyoğlu S. Indocyanine green 
and fundus fluorescein angiographic findings in patients with ac-
tive ocular Behcet’s disease. Ocul Immunol Inflamm 2005;13:51-8.
19. Nussenblatt RB, Kaufman SC, Palestine AG, Davis MD, Ferris FL 
3rd. Macular thickening and visual acuity. Measurement in patients 
with cystoid macular edema. Ophthalmology 1987;94:1134-9.
20. Nussenblatt RB, Whitcup SM. Uveitis: fundamentals and clinical 
practice. 4th ed. Philadelphia: Mosby; 2010.
21. Spitznas M. Understanding fluorescein angiography. Berlin: 
Springer; 2006.
22. Adamus G. Autoantibody-induced apoptosis as a possible mecha-
nism of autoimmune retinopathy. Autoimmun Rev 2003;2:63-8.
23. Chan CC, Palestine AG, Nussenblatt RB, Roberge FG, Benezra D. 
Anti-retinal auto-antibodies in Vogt-Koyanagi-Harada syndrome, 
Behcet’s disease, and sympathetic ophthalmia. Ophthalmology 
1985;92:1025-8.
24. Yilmaz G, Sizmaz S, Yilmaz ED, Duman S, Aydin P. Aqueous hu-
mor nitric oxide levels in patients with Behçet disease. Retina 
2002;22:330-5.
25. Rao NA, Wu GS. Free radical mediated photoreceptor damage in 
uveitis. Prog Retin Eye Res 2000;19:41-68.
26. Liversidge J, Dick A, Gordon S. Nitric oxide mediates apoptosis 
through formation of peroxynitrite and Fas/Fas-ligand interactions 
in experimental autoimmune uveitis. Am J Pathol 2002;160:905-16.
27. Rajendram R, Saraswathy S, Rao NA. Photoreceptor mitochondri-
al oxidative stress in early experimental autoimmune uveoretinitis. 
Br J Ophthalmol 2007;91:531-7. 
28. DiLoreto DA Jr, Bressler NM, Bressler SB, Schachat AP. Use of 
best and final visual acuity outcomes in ophthalmological research. 
Arch Ophthalmol 2003;121:1586-90.
In conclusion, this study demonstrated that posterior pole 
involvement, the degree of retinal vascular leakage, optic 
disc hyperfluorescence, and macular leakage are significant-
ly associated with worse VA in Behçet retinal vasculitis. 
This suggests that the proposed angiographic classification 
and grading of Behçet retinal vasculitis may be clinically sig-
nificant in terms of patients’ visual prognosis and physician’s 
treatment strategy.
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